Form 8-K - Current report:
SEC Accession No. 0001437749-25-021361
Filing Date
2025-06-26
Accepted
2025-06-26 17:21:37
Documents
22
Period of Report
2025-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20250626_8k.htm   iXBRL 8-K 43720
2 EXHIBIT 4.1 ex_834498.htm EX-4.1 94077
3 EXHIBIT 4.2 ex_834499.htm EX-4.2 95612
4 EXHIBIT 5.1 ex_834497.htm EX-5.1 11460
5 EXHIBIT 10.1 ex_834500.htm EX-10.1 203655
6 EXHIBIT 10.2 ex_834501.htm EX-10.2 50403
7 EXHIBIT 99.1 ex_834502.htm EX-99.1 10245
8 EXHIBIT 99.2 ex_834503.htm EX-99.2 11097
13 foopt.jpg GRAPHIC 8794
14 ls.jpg GRAPHIC 5686
  Complete submission text file 0001437749-25-021361.txt   818437

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA rvph-20250626.xsd EX-101.SCH 4083
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20250626_def.xml EX-101.DEF 13859
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20250626_lab.xml EX-101.LAB 18284
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20250626_pre.xml EX-101.PRE 13891
24 EXTRACTED XBRL INSTANCE DOCUMENT rvph20250626_8k_htm.xml XML 4988
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 251081396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)